IPO registrations (S-1, F-1) · Registrants
UNITED THERAPEUTICS Corp
- SEC CIK
- 1082554 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1999-04-16, last 2000-01-14; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2000-01-18
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1000 SPRING ST, Silver Spring, MD 20910
- EIN
- 52-1984749
- Ticker
- UTHR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- UNITED THERAPEUTICS Corp on the corporate pages
Offering terms
- Final price
- $32.00 per share (424B1 filed 2000-01-18, an initial public offering)
- Shares sold
- 2,500,000
- Gross proceeds
- $80,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol UTHR
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: UNITED THERAPEUTICS CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: United Therapeutics Corporation Fuzzy (name and state)
- Business registration: UNITED THERAPEUTICS CORPORATION Fuzzy (name and state)
- Business registration: UNITED THERAPEUTICS CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: UNITED THERAPEUTICS CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: UNITED THERAPEUTICS CORP Fuzzy (name and state)
- Lobbying client: UNITED THERAPEUTICS Fuzzy (name and state)
- Lobbying client: UNITED THERAPEUTICS CORPORATION Fuzzy (name and state)
- SEC filer: UNITED THERAPEUTICS Corp EXACT (CIK (EXACT))
- Person page: R Paul Gray Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-04-16 | S-1 | S-1 (registration) | UNITED THERAPEUTICS CORP | 0000950133-99-001367 ↗ |
| 1999-05-20 | S-1/A | S-1/A (amendment) | UNITED THERAPEUTICS CORP | 0000950133-99-001961 ↗ |
| 1999-06-10 | S-1/A | S-1/A (amendment) | UNITED THERAPEUTICS CORP | 0000950133-99-002148 ↗ |
| 1999-06-11 | S-1/A | S-1/A (amendment) | UNITED THERAPEUTICS CORP | 0000950133-99-002168 ↗ |
| 1999-06-15 | S-1/A | S-1/A (amendment) | UNITED THERAPEUTICS CORP | 0000950133-99-002201 ↗ |
| 1999-12-30 | S-1 | S-1 (registration) | UNITED THERAPEUTICS CORP | 0000950133-99-004047 ↗ |
| 2000-01-14 | S-1/A | S-1/A (amendment) | UNITED THERAPEUTICS CORP | 0000950133-00-000073 ↗ |
| 2000-01-18 | 424B1 | 424B1 (final prospectus) | UNITED THERAPEUTICS CORP | 0000950133-00-000103 ↗ |
| 2000-04-04 | 424B1 | 424B1 (final prospectus) | UNITED THERAPEUTICS CORP | 0000950133-00-001405 ↗ |
| 2000-06-26 | 424B1 | 424B1 (final prospectus) | UNITED THERAPEUTICS CORP | 0000950133-00-002681 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-01-14 | S-1/A | registration statement | $32.00 | 2,500,000 | $80,000,000 | Nasdaq UTHR | 0 | from the submission text; price sentence, shares headline, proceeds computed | document ↗ | |
| 2000-01-18 | 424B1 | final prospectus | $32.00 | 2,500,000 | $80,000,000 | Nasdaq UTHR | 0 | from the submission text; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| HADEED FRED T | Officer | EVP, Business Development; EVP & CFO | 16 | 2006 | |
| JEFFS ROGER | Director,Officer; Other | President 7 COO; President and COO; President & CO); President & Co-CEO; President & Coo; President & COO | 314 | 2006–2016 | |
| MAHON PAUL A | Director,Officer; Officer | EVP and General Counsel; EVP & CFO; EVP & General Counsel; EVP & GENERAL COUNSEL | 436 | 2006–2026 | |
| ROTHBLATT MARTINE A | Director; Director,Officer; Officer | CEO; Chairman & CEO; Chairman & Co-CEO; Chairperson & CEO; CHAIRPERSON & CEO | 1,005 | 2006–2026 | |
| KURZWEIL RAY | Director | 51 | 2006–2026 | ||
| CAUSEY CHRISTOPHER | Director | 188 | 2006–2026 | ||
| DWEK RAYMOND | Director | 110 | 2006–2025 | ||
| GRAY R PAUL | Director; Other | 40 | 2006–2014 | person page Fuzzy | |
| PATUSKY CHRISTOPHER | Director | 118 | 2006–2026 | ||
| SULLIVAN LOUIS W | Director | 64 | 2006–2026 | ||
| Ferrari John Maxim | Officer; Other | CFO; CFO & Treasurer; Chief Financial Officer | 105 | 2006–2015 | |
| LILLY ELI & CO | TenPercentOwner | Director, Chairman and CEO | 4 | 2008–2011 | |
| Giltner Richard | Director | 60 | 2009–2026 | ||
| Thompson Tommy G | Director | 65 | 2010–2026 | ||
| Klein Katherine J | Director | 16 | 2014–2024 | ||
| ZACCARDELLI DAVID | Officer; Other | EVP & Chief Operating Officer | 52 | 2015–2016 | |
| EDGEMOND JAMES | Officer | CFO and Treasurer; CFO AND TREASURER | 64 | 2015–2026 | |
| Olian Judy D. | Director | 40 | 2015–2026 | ||
| BENKOWITZ MICHAEL | Officer | President and COO; PRESIDENT AND COO | 99 | 2016–2026 | |
| Mesa Nilda | Director | 30 | 2018–2026 | ||
| MAXWELL LINDA | Director | 9 | 2020–2026 | ||
| MALCOLM JAN | Director | 15 | 2024–2026 | ||
| Tracey Kevin | Director | 3 | 2026 | ||
| DZAU VICTOR J | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | United Therapeutics Corporation | MD | State business registries | name and state |
| Business registration | UNITED THERAPEUTICS CORPORATION | MD | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | UNITED THERAPEUTICS CORPORATION | MD | State business registries | name and state |
| Business registration | UNITED THERAPEUTICS CORPORATION | MD | State business registries | name and state |
| Federal award recipient | UNITED THERAPEUTICS CORP | MD | Federal spending (USAspending) | name and state |
| Lobbying client | UNITED THERAPEUTICS | MD | Federal lobbying (LDA) | name and state |
| Lobbying client | UNITED THERAPEUTICS CORPORATION | MD | Federal lobbying (LDA) | name and state |
| Patent assignee | United Therapeutics Corporation | MD | Patents (USPTO) | name and state |
| SEC filer | UNITED THERAPEUTICS Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | United Therapeutics Corporation | MD | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | UNITED THERAPEUTICS CORPORATION | EIN (EXACT) | ||
| Person page | R Paul Gray | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MD first:
- NORTHWEST BIOTHERAPEUTICS INC MD
- INTERCELL USA, INC. MD
- MACROGENICS INC MD
- MiddleBrook Pharmaceuticals, Inc. MD
- AVALON PHARMACEUTICALS INC MD
- IGC Pharma, Inc. MD
- CNBX Pharmaceuticals Inc. MD
- PRECIGEN, INC. MD
- SUPERNUS PHARMACEUTICALS, INC. MD
- Sucampo Pharmaceuticals, Inc. MD
In other datasets, the same topic (Health) in MD:
- Nonprofit: 4K FOR CANCER INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health